Literature DB >> 22976935

Evidences of the inflammasome pathway in chronic prostatitis and chronic pelvic pain syndrome in an animal model.

Chih-Shou Chen1, Pey-Jium Chang, Wei-Yu Lin, Yun-Ching Huang, Dong-Ru Ho.   

Abstract

BACKGROUND: The mechanism of non-bacterial chronic prostatitis (CP/CPPS) has long been investigated but remains unclear. Under the hypothesis that abnormal response of innate immunity may be a cause of CP/CPPS, this study evaluated inflammasome, as part of innate immunity, and its effects on persist inflammation and CP/CPPS.
METHODS: Carrageenan was used to induce CP/CPPS in a rat animal model. After confirming tactile hyper-algesia in the rats, their local prostate inflammation status, and inflammasome expression were determined. The amount of inflammasome and its downstream protein was checked, along with prostate localization. Chlorogenic acid (CHA), an active ingredient of Chinese herbal remedy for CP/CPPS treatment, was used as treatment.
RESULTS: The rats had CP/CPPS once scrotal static tactile allodynia developed and CHA treatment relieved the scrotal hypersensitivity. Downstream inflammasome proteins like IL-1β and caspase 1 increased within the prostate and decreased with CHA treatment. Inflammasome, NALP1 but not NALP3, was significantly increased in the prostate glandular endothelial cells. Treatment with CHA also changed the distribution pattern of NALP1 in the prostate.
CONCLUSIONS: There is a close relationship between activation of inflammasome and patho-physiologic changes of CP/CPSS in rats. Increased inflammasome may be a possible mechanism of CP/CPPS and clinically active regimen may inhibit the inflammasome-related pathway. This provides a new therapeutic rationale and approach for CP/CPPS treatment.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976935     DOI: 10.1002/pros.22580

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  CD-163 correlated with symptoms (pain or discomfort) of prostatic inflammation.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Soichi Arakawa; Kazushi Tanaka; Masato Fujisawa
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

Review 3.  The inflammasome as a target for pain therapy.

Authors:  H Zhang; F Li; W-W Li; C Stary; J D Clark; S Xu; X Xiong
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

4.  Inflammasomes are important mediators of prostatic inflammation associated with BPH.

Authors:  Mahendra Kashyap; Subrata Pore; Zhou Wang; Jeffrey Gingrich; Naoki Yoshimura; Pradeep Tyagi
Journal:  J Inflamm (Lond)       Date:  2015-05-17       Impact factor: 4.981

5.  Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer.

Authors:  Dev Karan; Ossama Tawfik; Seema Dubey
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

6.  Prostate-Specific Deletion of Cdh1 Induces Murine Prostatic Inflammation and Bladder Overactivity.

Authors:  Laura E Pascal; Shinsuke Mizoguchi; Wei Chen; Lora H Rigatti; Taro Igarashi; Rajiv Dhir; Pradeep Tyagi; Zeyu Wu; Zhenyu Yang; William C de Groat; Donald B DeFranco; Naoki Yoshimura; Zhou Wang
Journal:  Endocrinology       Date:  2021-01-01       Impact factor: 5.051

7.  Development and validation of an animal model of prostate inflammation-induced chronic pelvic pain: evaluating from inflammation of the prostate to pain behavioral modifications.

Authors:  Feng Zeng; Hequn Chen; Jinrui Yang; Long Wang; Yu Cui; Xiao Guan; Zhao Wang; Jiping Niu; Xiongbing Zu; Lin Qi; Xiangyang Zhang; Zhengyan Tang; Longfei Liu
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

Review 8.  From Inflammation to Prostate Cancer: The Role of Inflammasomes.

Authors:  Dev Karan; Seema Dubey
Journal:  Adv Urol       Date:  2016-06-27

9.  Beneficial Effects of Inflammatory Cytokine-Targeting Aptamers in an Animal Model of Chronic Prostatitis.

Authors:  Dong-Ru Ho; Pey-Jium Chang; Wei-Yu Lin; Yun-Ching Huang; Jian-Hui Lin; Kuo-Tsai Huang; Wai-Nga Chan; Chih-Shou Chen
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

Review 10.  Role of the NLRP3 inflammasome in cancer.

Authors:  Maryam Moossavi; Negin Parsamanesh; Afsane Bahrami; Stephen L Atkin; Amirhossein Sahebkar
Journal:  Mol Cancer       Date:  2018-11-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.